FY2025 · ended May 31, 2025 · Revenue $3,750, -67.4% YoY · Filed Oct 17, 2025
Exousia Bio, Inc. (LMMY) files with the SEC under industry code 8200, Services-Educational Services. In fiscal 2025, which ended May 31, 2025, it reported revenue of $3,750 and net income of $51,395.
Revenue (TTM)
$0
-100.0% vs year-ago TTM
Net income (TTM)
$-80,161
-206.3% vs year-ago TTM
Operating cash flow (TTM)
$85,560
+0.5% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.01
-165.3% vs year-ago TTM
Dividend per share
None
Shares outstanding
7.78M
+0.0% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Services-Educational Services (SIC 8200)
- Listed as
- LMMY (OTC)
- Fiscal year ends
- May 31
- Incorporated in
- WY
- Headquarters
- St. Petersburg, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1939937
- Former names
- LAMY (until Jan 15, 2026); L A M Y (until Apr 15, 2024)
Other Services-Educational Services companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 May 31, 2025 |
FY 2024 May 31, 2024 |
FY 2023 May 31, 2023 |
|---|---|---|---|
| Revenue | $3,750 | $11,500 | $0 |
| Operating income | — | — | -$56,421 |
| Net income | $51,395 | -$25,807 | -$56,421 |
| Diluted EPS | $0.00 | $0.00 | $0.00 |
| Operating cash flow | -$4,528 | -$12,484 | -$38,111 |
| Total assets | $0 | $27,453 | $37,044 |
| Total liabilities | $0 | $82,348 | $66,132 |
| Stockholders' equity | $0 | -$54,895 | -$29,088 |
| Cash and investments | $0 | $1,028 | $7,855 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Jun 16, 2026 | Feb 28, 2026 |
| 10-Q | Quarterly report | Mar 17, 2026 | Nov 30, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control, Officer or director change
|
Nov 17, 2025 | Nov 11, 2025 |
| 10-Q | Quarterly report | Nov 17, 2025 | Aug 31, 2025 |
| 10-K | Annual report | Oct 17, 2025 | May 31, 2025 |
| 10-Q | Quarterly report | Apr 24, 2025 | Feb 28, 2025 |
All 50 Exousia Bio, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.